ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
6,1,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
7,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
8,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
